+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Angiotensin Receptor Blocker Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • PDF Icon

    Report

  • 111 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5945265
Description Jump to:

Quick Summary:

In the dynamic pharmaceutical landscape, the Angiotensin Receptor Blocker market stands out as a critical segment with far-reaching implications for public health management and strategic business expansion. Comprehending the intricacies of this market is indispensable for senior executives looking to navigate the complexities of hypertension, cardiovascular, and kidney disease treatments. Our comprehensive market research report serves as a pivotal resource for making informed decisions that can shape the future of your enterprise.

The research provides an exhaustive analysis of supply and demand dynamics, pricing trends, and the competitive landscape across five major geographical regions. With granular insight into key players including Pfizer, Novartis, and Merck, among others, the report equips you with essential data including company SWOT analyses, market share, and financial performance. By synthesizing historical data with forecasting, our report sets the stage for your next strategic move in the ever-evolving Angiotensin Receptor Blocker industry.

This report describes the global market size of Angiotensin Receptor Blocker from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Angiotensin Receptor Blocker as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Hypertension
  • Cardiovascular Diseases
  • Kidney Diseases
  • Other

Companies Covered:

  • Pfizer
  • Novartis
  • Merck
  • Astra Zeneca
  • Jhonson and Johnson
  • Eli Lilly and Company
  • Sanofi SA
  • Bristol-Myers Squibb
  • Bayer
  • GSK
  • Teva Pharmaceutical
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Angiotensin Receptor Blocker Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Angiotensin Receptor Blocker Market in North America (2019-2029)
8.1 Angiotensin Receptor Blocker Market Size
8.2 Angiotensin Receptor Blocker Market by End Use
8.3 Competition by Players/Suppliers
8.4 Angiotensin Receptor Blocker Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Angiotensin Receptor Blocker Market in South America (2019-2029)
9.1 Angiotensin Receptor Blocker Market Size
9.2 Angiotensin Receptor Blocker Market by End Use
9.3 Competition by Players/Suppliers
9.4 Angiotensin Receptor Blocker Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Angiotensin Receptor Blocker Market in Asia & Pacific (2019-2029)
10.1 Angiotensin Receptor Blocker Market Size
10.2 Angiotensin Receptor Blocker Market by End Use
10.3 Competition by Players/Suppliers
10.4 Angiotensin Receptor Blocker Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Angiotensin Receptor Blocker Market in Europe (2019-2029)
11.1 Angiotensin Receptor Blocker Market Size
11.2 Angiotensin Receptor Blocker Market by End Use
11.3 Competition by Players/Suppliers
11.4 Angiotensin Receptor Blocker Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Angiotensin Receptor Blocker Market in MEA (2019-2029)
12.1 Angiotensin Receptor Blocker Market Size
12.2 Angiotensin Receptor Blocker Market by End Use
12.3 Competition by Players/Suppliers
12.4 Angiotensin Receptor Blocker Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Angiotensin Receptor Blocker Market (2019-2024)
13.1 Angiotensin Receptor Blocker Market Size
13.2 Angiotensin Receptor Blocker Market by End Use
13.3 Competition by Players/Suppliers
13.4 Angiotensin Receptor Blocker Market Size by Type
Chapter 14 Global Angiotensin Receptor Blocker Market Forecast (2024-2029)
14.1 Angiotensin Receptor Blocker Market Size Forecast
14.2 Angiotensin Receptor Blocker Application Forecast
14.3 Competition by Players/Suppliers
14.4 Angiotensin Receptor Blocker Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Angiotensin Receptor Blocker Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
15.2 Novartis
15.2.1 Company Profile
15.2.2 Main Business and Angiotensin Receptor Blocker Information
15.2.3 SWOT Analysis of Novartis
15.2.4 Novartis Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
15.3 Merck
15.3.1 Company Profile
15.3.2 Main Business and Angiotensin Receptor Blocker Information
15.3.3 SWOT Analysis of Merck
15.3.4 Merck Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
15.4 Astra Zeneca
15.4.1 Company Profile
15.4.2 Main Business and Angiotensin Receptor Blocker Information
15.4.3 SWOT Analysis of Astra Zeneca
15.4.4 Astra Zeneca Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
15.5 Jhonson and Johnson
15.5.1 Company Profile
15.5.2 Main Business and Angiotensin Receptor Blocker Information
15.5.3 SWOT Analysis of Jhonson and Johnson
15.5.4 Jhonson and Johnson Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
15.6 Eli Lilly and Company
15.6.1 Company Profile
15.6.2 Main Business and Angiotensin Receptor Blocker Information
15.6.3 SWOT Analysis of Eli Lilly and Company
15.6.4 Eli Lilly and Company Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
15.7 Sanofi SA
15.7.1 Company Profile
15.7.2 Main Business and Angiotensin Receptor Blocker Information
15.7.3 SWOT Analysis of Sanofi SA
15.7.4 Sanofi SA Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
15.8 Bristol-Myers Squibb
15.8.1 Company Profile
15.8.2 Main Business and Angiotensin Receptor Blocker Information
15.8.3 SWOT Analysis of Bristol-Myers Squibb
15.8.4 Bristol-Myers Squibb Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
15.9 Bayer
15.9.1 Company Profile
15.9.2 Main Business and Angiotensin Receptor Blocker Information
15.9.3 SWOT Analysis of Bayer
15.9.4 Bayer Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
15.10 GSK
15.10.1 Company Profile
15.10.2 Main Business and Angiotensin Receptor Blocker Information
15.10.3 SWOT Analysis of GSK
15.10.4 GSK Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
15.11 Teva Pharmaceutical
15.11.1 Company Profile
15.11.2 Main Business and Angiotensin Receptor Blocker Information
15.11.3 SWOT Analysis of Teva Pharmaceutical
15.11.4 Teva Pharmaceutical Angiotensin Receptor Blocker Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Angiotensin Receptor Blocker Report
Table Data Sources of Angiotensin Receptor Blocker Report
Table Major Assumptions of Angiotensin Receptor Blocker Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Angiotensin Receptor Blocker Picture
Table Angiotensin Receptor Blocker Classification
Table Angiotensin Receptor Blocker Applications
Table Drivers of Angiotensin Receptor Blocker Market
Table Restraints of Angiotensin Receptor Blocker Market
Table Opportunities of Angiotensin Receptor Blocker Market
Table Threats of Angiotensin Receptor Blocker Market
Table COVID-19 Impact For Angiotensin Receptor Blocker Market
Table Raw Materials Suppliers
Table Different Production Methods of Angiotensin Receptor Blocker
Table Cost Structure Analysis of Angiotensin Receptor Blocker
Table Key End Users
Table Latest News of Angiotensin Receptor Blocker Market
Table Merger and Acquisition
Table Planned/Future Project of Angiotensin Receptor Blocker Market
Table Policy of Angiotensin Receptor Blocker Market
Table 2019-2029 North America Angiotensin Receptor Blocker Market Size
Figure 2019-2029 North America Angiotensin Receptor Blocker Market Size and CAGR
Table 2019-2029 North America Angiotensin Receptor Blocker Market Size by Application
Table 2019-2024 North America Angiotensin Receptor Blocker Key Players Revenue
Table 2019-2024 North America Angiotensin Receptor Blocker Key Players Market Share
Table 2019-2029 North America Angiotensin Receptor Blocker Market Size by Type
Table 2019-2029 United States Angiotensin Receptor Blocker Market Size
Table 2019-2029 Canada Angiotensin Receptor Blocker Market Size
Table 2019-2029 Mexico Angiotensin Receptor Blocker Market Size
Table 2019-2029 South America Angiotensin Receptor Blocker Market Size
Figure 2019-2029 South America Angiotensin Receptor Blocker Market Size and CAGR
Table 2019-2029 South America Angiotensin Receptor Blocker Market Size by Application
Table 2019-2024 South America Angiotensin Receptor Blocker Key Players Revenue
Table 2019-2024 South America Angiotensin Receptor Blocker Key Players Market Share
Table 2019-2029 South America Angiotensin Receptor Blocker Market Size by Type
Table 2019-2029 Brazil Angiotensin Receptor Blocker Market Size
Table 2019-2029 Argentina Angiotensin Receptor Blocker Market Size
Table 2019-2029 Chile Angiotensin Receptor Blocker Market Size
Table 2019-2029 Peru Angiotensin Receptor Blocker Market Size
Table 2019-2029 Asia & Pacific Angiotensin Receptor Blocker Market Size
Figure 2019-2029 Asia & Pacific Angiotensin Receptor Blocker Market Size and CAGR
Table 2019-2029 Asia & Pacific Angiotensin Receptor Blocker Market Size by Application
Table 2019-2024 Asia & Pacific Angiotensin Receptor Blocker Key Players Revenue
Table 2019-2024 Asia & Pacific Angiotensin Receptor Blocker Key Players Market Share
Table 2019-2029 Asia & Pacific Angiotensin Receptor Blocker Market Size by Type
Table 2019-2029 China Angiotensin Receptor Blocker Market Size
Table 2019-2029 India Angiotensin Receptor Blocker Market Size
Table 2019-2029 Japan Angiotensin Receptor Blocker Market Size
Table 2019-2029 South Korea Angiotensin Receptor Blocker Market Size
Table 2019-2029 Southeast Asia Angiotensin Receptor Blocker Market Size
Table 2019-2029 Australia Angiotensin Receptor Blocker Market Size
Table 2019-2029 Europe Angiotensin Receptor Blocker Market Size
Figure 2019-2029 Europe Angiotensin Receptor Blocker Market Size and CAGR
Table 2019-2029 Europe Angiotensin Receptor Blocker Market Size by Application
Table 2019-2024 Europe Angiotensin Receptor Blocker Key Players Revenue
Table 2019-2024 Europe Angiotensin Receptor Blocker Key Players Market Share
Table 2019-2029 Europe Angiotensin Receptor Blocker Market Size by Type
Table 2019-2029 Germany Angiotensin Receptor Blocker Market Size
Table 2019-2029 France Angiotensin Receptor Blocker Market Size
Table 2019-2029 United Kingdom Angiotensin Receptor Blocker Market Size
Table 2019-2029 Italy Angiotensin Receptor Blocker Market Size
Table 2019-2029 Spain Angiotensin Receptor Blocker Market Size
Table 2019-2029 Belgium Angiotensin Receptor Blocker Market Size
Table 2019-2029 Netherlands Angiotensin Receptor Blocker Market Size
Table 2019-2029 Austria Angiotensin Receptor Blocker Market Size
Table 2019-2029 Poland Angiotensin Receptor Blocker Market Size
Table 2019-2029 Russia Angiotensin Receptor Blocker Market Size
Table 2019-2029 MEA Angiotensin Receptor Blocker Market Size
Figure 2019-2029 MEA Angiotensin Receptor Blocker Market Size and CAGR
Table 2019-2029 MEA Angiotensin Receptor Blocker Market Size by Application
Table 2019-2024 MEA Angiotensin Receptor Blocker Key Players Revenue
Table 2019-2024 MEA Angiotensin Receptor Blocker Key Players Market Share
Table 2019-2029 MEA Angiotensin Receptor Blocker Market Size by Type
Table 2019-2029 Egypt Angiotensin Receptor Blocker Market Size
Table 2019-2029 Israel Angiotensin Receptor Blocker Market Size
Table 2019-2029 South Africa Angiotensin Receptor Blocker Market Size
Table 2019-2029 Gulf Cooperation Council Countries Angiotensin Receptor Blocker Market Size
Table 2019-2029 Turkey Angiotensin Receptor Blocker Market Size
Table 2019-2024 Global Angiotensin Receptor Blocker Market Size by Region
Table 2019-2024 Global Angiotensin Receptor Blocker Market Size Share by Region
Table 2019-2024 Global Angiotensin Receptor Blocker Market Size by Application
Table 2019-2024 Global Angiotensin Receptor Blocker Market Share by Application
Table 2019-2024 Global Angiotensin Receptor Blocker Key Vendors Revenue
Figure 2019-2024 Global Angiotensin Receptor Blocker Market Size and Growth Rate
Table 2019-2024 Global Angiotensin Receptor Blocker Key Vendors Market Share
Table 2019-2024 Global Angiotensin Receptor Blocker Market Size by Type
Table 2019-2024 Global Angiotensin Receptor Blocker Market Share by Type
Table 2024-2029 Global Angiotensin Receptor Blocker Market Size by Region
Table 2024-2029 Global Angiotensin Receptor Blocker Market Size Share by Region
Table 2024-2029 Global Angiotensin Receptor Blocker Market Size by Application
Table 2024-2029 Global Angiotensin Receptor Blocker Market Share by Application
Table 2024-2029 Global Angiotensin Receptor Blocker Key Vendors Revenue
Figure 2024-2029 Global Angiotensin Receptor Blocker Market Size and Growth Rate
Table 2024-2029 Global Angiotensin Receptor Blocker Key Vendors Market Share
Table 2024-2029 Global Angiotensin Receptor Blocker Market Size by Type
Table 2024-2029 Angiotensin Receptor Blocker Global Market Share by Type

Companies Mentioned

  • Pfizer
  • Novartis
  • Merck
  • Astra Zeneca
  • Jhonson and Johnson
  • Eli Lilly and Company
  • Sanofi SA
  • Bristol-Myers Squibb
  • Bayer
  • GSK
  • Teva Pharmaceutical

Methodology

Loading
LOADING...

Related Topics

Related Reports

Angiotensin Receptor Blockers (ARBs) Global Market Report 2024 - Product Image

Angiotensin Receptor Blockers (ARBs) Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Dilated Cardiomyopathy Therapeutics - Global Strategic Business Report - Product Image

Dilated Cardiomyopathy Therapeutics - Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Fibromuscular Dysplasia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Fibromuscular Dysplasia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • Global
From
Angiotensin type 1 receptor antagonists - Pipeline Insight, 2024 - Product Image

Angiotensin type 1 receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
ACE/ARB Inhibitors - Pipeline Insight, 2024 - Product Image

ACE/ARB Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.